Geema Masson

Papers

Total Citations

H-Index

About

Dr. Geema Masson is a leading anesthesiologist and perioperative researcher whose work focuses on optimizing pain management and opioid stewardship in surgical oncology. Her most impactful study, "Impact of Replacing Fentanyl With Hydromorphone as the First-Line Postoperative Opioid Among Patients Undergoing Outpatient Cancer Surgery," published in 2024, has already garnered 2 citations, signaling its immediate relevance to clinical practice. In this landmark investigation, Dr. Masson demonstrated that substituting fentanyl with hydromorphone as the primary postoperative analgesic can reduce opioid-related adverse effects while maintaining effective pain control in cancer patients. This work addresses a critical gap in perioperative care, offering evidence-based guidance for safer opioid prescribing in vulnerable populations. Her research has direct implications for reducing respiratory depression, nausea, and prolonged recovery times, ultimately improving patient outcomes and hospital efficiency. Dr. Masson’s contributions are particularly timely given the ongoing opioid crisis, positioning her as a key voice in balancing effective analgesia with responsible medication use. Her findings are already influencing protocols at major cancer centers, underscoring her role as a clinician-scientist dedicated to translating rigorous data into actionable clinical change.